share_log

iBio Inc | 4: Statement of changes in beneficial ownership of securities-Officer Duran Felipe

iBio Inc | 4: Statement of changes in beneficial ownership of securities-Officer Duran Felipe

iBio Inc | 4:持股變動聲明-高管 Duran Felipe
美股SEC公告 ·  05/14 04:34

Moomoo AI 已提取核心訊息

Felipe Duran, the Chief Financial Officer of iBio Inc (IBIO.US), was involved in a transaction with the company's stock on May 9, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the implications of the transaction on their investment decisions.
Felipe Duran, the Chief Financial Officer of iBio Inc (IBIO.US), was involved in a transaction with the company's stock on May 9, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the implications of the transaction on their investment decisions.
iBio Inc(IBIO.US)的首席財務官費利佩·杜蘭於2024年5月9日參與了該公司股票的交易。公告中未披露交易的具體細節,例如行動類型、狀態、股票數量、股票性質、交易價格和交易後持有量。這些信息對於投資者了解交易對其投資決策的影響至關重要。
iBio Inc(IBIO.US)的首席財務官費利佩·杜蘭於2024年5月9日參與了該公司股票的交易。公告中未披露交易的具體細節,例如行動類型、狀態、股票數量、股票性質、交易價格和交易後持有量。這些信息對於投資者了解交易對其投資決策的影響至關重要。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息